We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Jack Henry & Associates
JKHY
$10.5B
| $2.17M | ﹤0.01% |
15,638
+11,937
| +323% | +$1.58M |
|
852
Genworth Financial
GNW
$3.8B
| $2.17M | ﹤0.01% |
565,259
+134,109
| +31% | +$587K |
|
|
VAR
853
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.15M | ﹤0.01% |
15,164
+10,847
| +251% | +$1.42M |
|
854
Emcor
EME
$34.2B
| $2.14M | ﹤0.01% |
29,321
+63
| +0.2% | +$4.27K |
|
855
Omnicom Group
OMC
$22.2B
| $2.14M | ﹤0.01% |
29,274
+1,347
| +5% | +$101K |
|
856
Ryder
R
$10.4B
| $2.13M | ﹤0.01% |
34,368
-4,039
| -11% | -$236K |
|
|
TCO
857
DELISTED
Taubman Centers Inc.
TCO
| $2.13M | ﹤0.01% |
40,265
+9,270
| +30% | +$469K |
|
858
COPT Defense Properties
CDP
$4.25B
| $2.12M | ﹤0.01% |
77,527
+13,842
| +22% | +$350K |
|
859
NNN REIT
NNN
$9.25B
| $2.12M | ﹤0.01% |
38,175
-8,625
| -18% | -$447K |
|
860
Globe Life
GL
$13.3B
| $2.1M | ﹤0.01% |
25,592
+14,438
| +129% | +$1.18M |
|
|
BNY
861
Bank of New York Mellon
BNY
$109B
| $2.1M | ﹤0.01% |
41,567
-5,001,376
| -99% | -$258M |
|
862
Mettler-Toledo International
MTD
$26.9B
| $2.09M | ﹤0.01% |
2,885
+2,294
| +388% | +$1.49M |
|
|
ASNA
863
DELISTED
Ascena Retail Group, Inc.
ASNA
| $2.08M | ﹤0.01% |
96,381
+28,862
| +43% | +$1.29M |
|
864
Nucor
NUE
$54.9B
| $2.08M | ﹤0.01% |
35,641
-11,151
| -24% | -$654K |
|
865
Abercrombie & Fitch
ANF
$4.04B
| $2.07M | ﹤0.01% |
75,462
-21,350
| -22% | -$479K |
|
866
Scansource
SCSC
$1.1B
| $2.02M | ﹤0.01% |
56,333
+2,361
| +4% | +$88.2K |
|
867
Thor Industries
THO
$3.9B
| $2.01M | ﹤0.01% |
32,223
-3,777
| -10% | -$239K |
|
868
Dick's Sporting Goods
DKS
$18.3B
| $2M | ﹤0.01% |
54,432
-18,676
| -26% | -$666K |
|
869
PACCAR
PCAR
$68.8B
| $1.97M | ﹤0.01% |
43,425
-10,274
| -19% | -$447K |
|
870
C.H. Robinson
CHRW
$24.2B
| $1.97M | ﹤0.01% |
22,587
+376
| +2% | +$33K |
|
|
BKS
871
DELISTED
Barnes & Noble
BKS
| $1.95M | ﹤0.01% |
359,145
+81,271
| +29% | +$495K |
|
872
Applied Industrial Technologies
AIT
$12.7B
| $1.95M | ﹤0.01% |
32,762
+4,072
| +14% | +$236K |
|
873
Meritage Homes
MTH
$4.77B
| $1.94M | ﹤0.01% |
86,954
-6,978
| -7% | -$149K |
|
874
ArcBest
ARCB
$3.5B
| $1.94M | ﹤0.01% |
62,935
+8,421
| +15% | +$304K |
|
|
WPX
875
DELISTED
WPX Energy, Inc.
WPX
| $1.94M | ﹤0.01% |
147,641
-605,355
| -80% | -$7.6M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.